DE60232155D1 - Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen - Google Patents

Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen

Info

Publication number
DE60232155D1
DE60232155D1 DE60232155T DE60232155T DE60232155D1 DE 60232155 D1 DE60232155 D1 DE 60232155D1 DE 60232155 T DE60232155 T DE 60232155T DE 60232155 T DE60232155 T DE 60232155T DE 60232155 D1 DE60232155 D1 DE 60232155D1
Authority
DE
Germany
Prior art keywords
protein
hcv
hepatitis
structural
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232155T
Other languages
English (en)
Inventor
Roberto Burioni
Massimo Clementi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Antibodies and Biotechnologies Srl
Original Assignee
General Antibodies and Biotechnologies Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Antibodies and Biotechnologies Srl filed Critical General Antibodies and Biotechnologies Srl
Application granted granted Critical
Publication of DE60232155D1 publication Critical patent/DE60232155D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60232155T 2001-06-13 2002-06-11 Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen Expired - Lifetime DE60232155D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000336A ITRM20010336A1 (it) 2001-06-13 2001-06-13 Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi
PCT/IT2002/000384 WO2002100900A2 (en) 2001-06-13 2002-06-11 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof

Publications (1)

Publication Number Publication Date
DE60232155D1 true DE60232155D1 (de) 2009-06-10

Family

ID=11455593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232155T Expired - Lifetime DE60232155D1 (de) 2001-06-13 2002-06-11 Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen

Country Status (8)

Country Link
US (1) US7314919B2 (de)
EP (1) EP1417233B1 (de)
AT (1) ATE430167T1 (de)
AU (1) AU2002317474A1 (de)
DE (1) DE60232155D1 (de)
DK (1) DK1417233T3 (de)
IT (1) ITRM20010336A1 (de)
WO (1) WO2002100900A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143482A1 (de) * 2003-02-19 2010-01-13 Natrix Separations Inc. Geträgerte poröse Gele umfassende Verbundmaterialien
DE602006012836D1 (de) * 2005-06-02 2010-04-22 Akira Matsumori Verfahren zur sichtung von anti-hepatits c virus kandidaten
US7705138B2 (en) 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
EP2392588A3 (de) 2005-11-11 2012-03-07 Vertex Pharmaceuticals Incorporated Hepatitis-C-Virusvarianten
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
CA2678888C (en) 2007-02-21 2015-04-14 University Of Massachusetts Human antibodies against hepatitis c virus (hcv) and uses thereof
EP2272862B1 (de) 2009-07-10 2012-03-21 Freie Universität Berlin rock2 und rock3, zwei neue Gain-of-Function-Varianten der Cytokininrezeptoren AHK2 und AHK3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
DE60043708D1 (de) * 1999-10-13 2010-03-04 Novartis Vaccines & Diagnostic Verfahren zur erhaltung zellimmuneantworten gegen proteinen

Also Published As

Publication number Publication date
WO2002100900A2 (en) 2002-12-19
EP1417233A2 (de) 2004-05-12
ATE430167T1 (de) 2009-05-15
EP1417233B1 (de) 2009-04-29
US7314919B2 (en) 2008-01-01
US20040214994A1 (en) 2004-10-28
WO2002100900A3 (en) 2004-03-04
ITRM20010336A0 (it) 2001-06-13
AU2002317474A1 (en) 2002-12-23
DK1417233T3 (da) 2009-06-29
ITRM20010336A1 (it) 2002-12-13

Similar Documents

Publication Publication Date Title
EP1043399A3 (de) Hepatitis C Virus Zellkultursystem
BRPI0111682B8 (pt) suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio
BRPI0516356A (pt) terapia à base de levedura para infecções crÈnicas da hepatite c
ATE286067T1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
EP1200109A4 (de) Verwendung von peptid-nukleinsäureverbindungen zur auslösung zellulärer immunantworten gegen hepatitis c
WO2006096459A3 (en) Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof
FR2855758B1 (fr) Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
DE59109221D1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
WO2006039326A3 (en) Inhibitors of hepatitits c virus
NO20051715L (no) HCV assay
DE60232155D1 (de) Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen
WO2006024020A3 (en) Hcv non-structural protein mutants and uses thereof
ATE534666T1 (de) Antikörper gegen den hepatitis c-virus e1e2 komplex und pharmazeutische zusammensetzungen
DE69928064D1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
WO2004014936A3 (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications.
FI923020A (fi) Inte a inte b-sekvenser.
NO20024325D0 (no) Rensede hepatitt C-viruskappeproteiner for diagnostisk og terapeutisk anvendelse
FR2825093B1 (fr) Polypeptide reagissant avecles anticorps de patients infectes par vhc et utilisations
WO2007010398A3 (en) Caveolin-3 and in vitro culture of hepatitis c virus
EP1310512A3 (de) HCV-Kernprotein-Sequenzen
ATE338061T1 (de) Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen
AU2003250394A1 (en) Use of hepatitis c virus (hcv) p7 protein
IT1270941B (it) Peptidi di hcv e loro usi.
WO2002082089A3 (en) Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases
AR031456A1 (es) Proteinas que se unen a hcv y su uso medico diagnostico y de purificacion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition